TCT 414: Clinical outcomes of TAVR with an extra-large balloon-expandable valve for non-calcified aortic regurgitation: The PURE (Percutaneous Updated Managment of Aortic Regurgitartion) Study
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation